Rani Therapeutics Holdings RANI
NASDAQ RANI
$0.80 +0.00 (+0.57%)
At close: Oct 1, 2026 · 4:00 PM EDT

Rani Therapeutics Holdings (RANI) Research & Development (2020 - 2026)

Updated

Rani Therapeutics Holdings (RANI) reported Research & Development of $5.02 million for Q2 2026, down 8.9% from $5.51 million a year earlier and down 2.8% from the prior quarter.

Analysis

Rani Therapeutics Holdings (RANI) Research & Development (2020 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, Rani Therapeutics Holdings' Research & Development came in at $18.31 million, down 26.9% year-over-year; for FY2025, it came in at $20.21 million, down 24.3% from FY2024.

  • Research & Development has a five-year compound annual growth rate of 10.9% (FY2020 to FY2025).
  • By year, Research & Development came in at $26.68 million in FY2024 (-32.7%), $39.62 million in FY2023 (+8.2%), $36.61 million in FY2022 (+38.2%) and $26.48 million in FY2021 (+119.9%).
  • Five-year quarterly Research & Development spans a low of $3.22 million in Q3 2025 and a high of $11.96 million in Q3 2021.
  • Year over year, Research & Development has now declined in each of the last 11 quarters, with an average decline of 23.1% over the last eight quarters.
  • The high point for year-over-year Research & Development in five years was Q3 2021 (growth of 472.2%); the low point was Q3 2025 (a decline of 47.8%).
  • Per Business Quant data, the three quarters before Q2 2026 came in at $5.16 million (Q1 2026), $4.91 million (Q4 2025) and $3.22 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) R&D (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 3.65 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 2.34 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 9.74 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -2.85 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -4.05 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 1.87 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 1.76 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 2.81 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 993.80 Mn
10 Rani Therapeutics Holdings 147.86 Mn 156.61 Mn - 5.02 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 5.02 Mn
Mar 31, 2026 5.16 Mn
Dec 31, 2025 4.91 Mn
Sep 30, 2025 3.22 Mn
Jun 30, 2025 5.51 Mn
Mar 31, 2025 6.57 Mn
Dec 31, 2024 6.81 Mn
Sep 30, 2024 6.17 Mn
Jun 30, 2024 6.12 Mn
Mar 31, 2024 7.59 Mn
Dec 31, 2023 7.61 Mn
Sep 30, 2023 11.22 Mn
Jun 30, 2023 11.09 Mn
Mar 31, 2023 9.71 Mn
Dec 31, 2022 10.39 Mn
Sep 30, 2022 9.10 Mn
Jun 30, 2022 9.53 Mn
Mar 31, 2022 7.59 Mn
Dec 31, 2021 7.42 Mn
Sep 30, 2021 11.96 Mn
API Access

Rani Therapeutics Holdings Research & Development API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=research-and-development&ticker=RANI&period=max&api_key=YOUR_API_KEY